TY  - JOUR
AU  - López Relaño,Juan
AU  - Martín Adrados, Beatriz
AU  - Real Arévalo, Irene
AU  - Lozano Bartolomé, Javier
AU  - Abós, Beatriz
AU  - Sánchez Ramón, Silvia María
AU  - Alonso, Bárbara
AU  - Gómez Del Moral Martín-Consuegra, Manuel María
AU  - Martínez Naves, Eduardo
PY  - 2018
DO  - 10.3389/fimmu.2018.01328
SN  - 1664-3224
UR  - https://hdl.handle.net/20.500.14352/92259
T2  - Frontiers in Immunology
AB  - Lenalidomide is an analog of thalidomide, with potent anticancer activity demonstrated in several hematological malignancies. It has immunomodulatory properties, being able to enhance the activation of different types of immune cells, which results in...
LA  - eng
PB  - Frontiers Media
KW  - NKT cell
KW  - T-cells
KW  - Antigen presentation
KW  - Cytokines
KW  - Dendritic cells
KW  - Lenalidomide
KW  - Phagocytosis
TI  - Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability
TY  - journal article
VL  - 9
ER  -